SUPHA PHARMACHEM LIMITED (SUPHA)

BSE: ₹0.34
Stock Performance
Corporate Announcements
No recent announcements available.

Quarterly Financials

Consolidated Standalone
Particulars Mar 2025 Jun 2025 Sep 2025
Revenue from Operations 264.32 113.37 111.06
YOY Revenue Growth % - - -
Other Income 0.66 3.48 3.25
Total Income 264.98 116.84 114.31
Total Expenses + 266.38 111.13 103.88
Cost of Materials Consumed 0.00 0.00 0.00
Employee Benefit Expense 0.09 0.20 0.19
Other Expenses 2.02 3.47 3.02
Operating Profit -2.06 2.24 7.18
OPM % -0.8% 2% 6.5%
Profit Before Tax + -1.40 5.71 10.44
Tax Expense 0.65 1.06 1.81
Tax % - 18.6% 17.4%
Profit After Tax -2.05 4.65 8.62
EPS (Basic) -0.05 0.05 0.10

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025
Revenue from Operations 405.25
YOY Revenue Growth % -
Other Income 10.80
Total Income 416.05
Total Expenses + 411.67
Employee Benefit Expense 0.76
Other Expenses 7.45
Operating Profit -6.42
OPM % -1.6%
Profit Before Exceptional 4.38
Exceptional Items 0.00
Profit Before Tax + 4.38
Tax Expense 2.25
Tax % 51.4%
Profit After Tax 2.13
EPS (Basic) 0.05

Balance Sheet

Particulars Mar 2025
ASSETS
Non-Current Assets + 0.04
Property, Plant & Equipment 0.01
Capital Work in Progress 0.00
Non-Current Investments 0.00
Goodwill 0.00
Other Intangible Assets 0.00
Current Assets + 1,720.31
Inventories 269.38
Trade Receivables 771.62
Cash and Cash Equivalents 0.28
Current Investments 0.00
LIABILITIES & EQUITY
Total Equity 43.89
Equity Share Capital 40.32
Other Equity 3.57
Non-Current Liabilities 0.00
Current Liabilities 1,676.46
Total Liabilities 1,676.46

Cash Flow Statement

Particulars Mar 2025
Cash from Operating Activities -1,134.81
Cash from Investing Activities 0.13
Cash from Financing Activities 1,136.10
Net Increase/Decrease in Cash 1.43